Clinical and microbiologic characteristics of tcdA-negative variant clostridium difficile infections

BMC Infectious Diseases, 05/10/2012

The clinical course of A–B+ CDI is not different from that of A+B+ CDI. Clindamycin use is a significant risk factor for the acquisition of tcdA–negative variant strains.

Print Article Summary Cat 2 CME Report